How effective is letrozole (Femara 2.5 mg) in managing hormone-sensitive breast cancer and what evidence supports its ability to reduce the risk of recurrence?
Lakshya KumarExplorer
How effective is letrozole (Femara 2.5 mg) in treating hormone-sensitive breast cancer and can it prevent recurrence?
Share
Letrozole is highly effective in treating hormone-sensitive breast cancer, reducing recurrence risk by about 43% compared to tamoxifen, according to a study published in the New England Journal of Medicine.